What is oxytocin, and can it help couples bond?

What happened on October 7, 2026?

On October 7, 2026, a clip of Palmer Luckey circulated on X. Asked what startup he would build today, he answered in two lines that traveled farther than a product announcement.

The public post of that clip, shared by @dnapway, drew more than 1.4 million views within a day. People searched his name next to oxytocin, next to divorce, and next to marriage counseling.

This page is commentary on that public remark and on the studies it points toward. It is not an advertisement, and it is not an endorsement. The only words attributed to him here are the two sentences below, taken from that clip as text. Nothing from the video is quoted beyond them.

Palmer Luckey is not affiliated with and has not endorsed VevaMD.

What is oxytocin?

Oxytocin is a peptide hormone. The body makes it in the hypothalamus and releases it from the posterior pituitary. In ordinary speech it is the bonding hormone, sometimes the love hormone, because research has tied it to closeness, touch, and the preference for a familiar partner.

The FDA-approved drug is an injection. Pitocin and equivalent oxytocin injections are indicated for medically needed induction or stimulation of labor, and for uterine contraction after birth. The label does not list pair bonding, intimacy, or marriage counseling as a use. [7]

A nickname from the research is not a use on a label. Calling oxytocin the bonding hormone describes what scientists have studied. It does not say what a compounded product will do for any couple.

What does prairie vole research say about pair bonding?

Prairie voles, Microtus ochrogaster, are one of the few mammals that form an enduring preference for a single partner. That preference is the behavior scientists measure when they talk about pair bonding in this species. The work is why a public comment could say, fairly, that mammal pair bonding is something the field understands pretty well.

Williams, Insel, Harbaugh, and Carter (1994) gave female prairie voles oxytocin through a pump into the brain, then housed each female with a male for six hours. Females that received central oxytocin at 10 or 100 nanograms per hour preferred that male over a stranger. Oxytocin under the skin did not produce the preference. A drug that blocks the oxytocin receptor stopped the effect of the oxytocin that was given. [1]

Insel and Hulihan (1995) came at it from the other direction. Female prairie voles that had not mated developed a partner preference after an oxytocin infusion, and not after vasopressin or inert fluid. Females given an oxytocin antagonist mated normally and still failed to form the preference. A vasopressin antagonist did not block it. The authors noted that earlier work in males of this species had pointed to vasopressin rather than oxytocin. [2]

Young and Wang (2004) reviewed the line in Nature Neuroscience. Their model: oxytocin and vasopressin help the brain tell one individual from another, and dopamine in reward circuits stamps that individual as the partner. Species that do not pair-bond show a different pattern of receptors. The review says the findings have intriguing implications for social attachment in our own species. It is a review of rodent experiments. It is not a prescription study in people. [3]

What have human studies found about oxytocin, couples, and communication?

Ditzen and colleagues (2009) ran a double-blind, placebo-controlled study with 47 heterosexual couples, 94 people. Each person received intranasal oxytocin or a placebo, then the couple had a structured conflict conversation in a lab. Researchers coded behavior and measured salivary cortisol.

Oxytocin increased positive communication behavior relative to negative behavior (F = 4.18, p = .047) and reduced cortisol after the conflict compared with placebo (F = 7.14, p = .011). It did not change the total duration of positive behavior, or of negative behavior, on its own. Couples rated the conversation as much like one they would have at home. This was a single laboratory dose. It was not a course of medicine, and it did not measure whether the couples stayed together. [4]

Scheele and colleagues (2012) asked what a research spray does to the distance a man keeps from a woman who is not his partner. In a randomized, placebo-controlled trial, men in a monogamous relationship kept about 10 to 15 centimeters more distance from an attractive woman after oxytocin. Single men did not. The shift showed up with a female experimenter, not a male one, and it did not change how attractive or arousing the men rated the woman. The authors suggested this could be one way the hormone supports a bond that already exists. It is a finding about a first encounter in a lab. [5]

What does research say about oxytocin, touch, and closeness?

Holt-Lunstad, Birmingham, and Light (2008) assigned 34 healthy married couples either to a four-week warm-touch program or to a monitoring group. Salivary oxytocin rose in the touch group. Husbands in that group had lower 24-hour systolic blood pressure afterward. [6]

The intervention was touch, not a drug. Higher oxytocin was something the researchers measured, not something they administered. Warm touch and a prescription are different questions.

Read as a set, the human papers explore communication under a research spray, physical distance under a research spray, and the body’s own oxytocin when couples touch more. They do not show that taking oxytocin holds a relationship together.

How is intranasal oxytocin different from a strip, troche, gummy, or spray?

The human experiments above used intranasal oxytocin prepared for a study, given once, in a lab, against a placebo. The FDA-approved oxytocin product is an injection used in a hospital for labor and the period after birth. [7]

A dissolving strip, a cheek troche, a gummy, and a compounded nasal spray are different dosage forms. A compounded preparation is made by a pharmacy for one person’s prescription. It is not FDA-approved. A finding about a research spray, or about an injection used in labor, does not establish what another form will do.

No paper in the reference list below tested a compounded strip, troche, gummy, or nasal spray for pair bonding. Anyone reading a headline about marriage counseling should keep that gap in view.

What are the safety issues and side effects?

Limited data exist on the safety and effectiveness of oxytocin for sexual health, and a standard dose for that use has not been established. Effects listed for oxytocin include mild headache, nausea, a temporary change in blood pressure, and a change in mood.

People with poorly controlled blood pressure or known heart disease are told not to take these products. A combination that also contains tadalafil is not for someone who takes nitrates for chest pain, uses poppers, has severe heart or liver problems, has very low blood pressure, or had a recent stroke or heart attack.

A gummy that also contains PT-141 (bremelanotide) is not the FDA-approved product Vyleesi. That label names nausea as the most common side effect. [8]

Chest pain, trouble breathing, extreme dizziness, or swelling of the face, lips, tongue, or throat needs emergency care. Call 911. Tell a physician if you are pregnant or might be: the approved form of this hormone is used to contract the uterus.

Who is this for, and who is it not for?

The research is relevant to adults who want to understand the science of closeness, and to adults who may later ask a licensed physician whether a compounded product is appropriate for them. The honest reading is narrow. The studies are real. The leap from a vole, or from one lab visit, to a couple’s future is not a result the papers report.

It is not for someone who wants a guaranteed change in a relationship. It is not a substitute for counseling. It is not for someone with poorly controlled blood pressure or known heart disease. It is not an emergency service.

Compounded oxytocin is not FDA-approved for this use. Individual results vary. A licensed physician decides if it is appropriate.

Can you get oxytocin prescribed online?

A licensed physician can review an online intake and decide whether a prescription is appropriate. The prescription is not guaranteed. In the United States, a compounded medicine is dispensed by a licensed pharmacy after that decision, for a specific person.

VevaMD is a technology and marketing company, not a medical provider. Physicians who review VevaMD intakes are on our clinical team. Each person needs their own intake and their own review. Partners are not reviewed as one chart.

VevaMD offers compounded oxytocin through licensed physicians.

Key facts

• Oxytocin is a hormone made in the hypothalamus. The FDA-approved injection is for labor and postpartum care, not for bonding. [7]
• In female prairie voles, oxytocin in the brain facilitated a partner preference, and blocking the receptor prevented it. [1] [2]
• A 2004 review describes pair bonding as partner recognition plus reward, and limits the human point to an implication. [3]
• In 47 couples, one laboratory dose of intranasal oxytocin shifted the balance of positive to negative communication and lowered cortisol. Total positive time and total negative time did not change. [4]
• Men who already had a partner kept about 10 to 15 centimeters more distance from an attractive stranger after intranasal oxytocin. Single men did not. [5]
• A warm-touch program among married couples was followed by higher salivary oxytocin. The study did not give oxytocin as a drug. [6]
• Palmer Luckey is not affiliated with and has not endorsed VevaMD.

Questions people are asking

References

1. 1. Williams JR, Insel TR, Harbaugh CR, Carter CS. Oxytocin administered centrally facilitates formation of a partner preference in female prairie voles (Microtus ochrogaster). J Neuroendocrinol. 1994;6(3):247-250. PMID 7920590. pubmed.ncbi.nlm.nih.gov/7920590/Central oxytocin, not a dose under the skin, facilitated a partner preference. An oxytocin-receptor blocker prevented it.
2. 2. Insel TR, Hulihan TJ. A gender-specific mechanism for pair bonding: oxytocin and partner preference formation in monogamous voles. Behav Neurosci. 1995;109(4):782-789. PMID 7576222. pubmed.ncbi.nlm.nih.gov/7576222/In female prairie voles, oxytocin produced a partner preference without mating. An oxytocin blocker stopped the preference that follows mating.
3. 3. Young LJ, Wang Z. The neurobiology of pair bonding. Nat Neurosci. 2004;7(10):1048-1054. doi.org/10.1038/nn1327A review of the vole model. The authors call the human implications intriguing. They did not test a human product.
4. 4. Ditzen B, Schaer M, Gabriel B, Bodenmann G, Ehlert U, Heinrichs M. Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict. Biol Psychiatry. 2009;65(9):728-731. PMID 19027101. pubmed.ncbi.nlm.nih.gov/19027101/47 heterosexual couples. One laboratory dose. More positive communication relative to negative, and lower cortisol. Total positive time and total negative time did not change.
5. 5. Scheele D, Striepens N, Güntürkün O, Deutschländer S, Maier W, Kendrick KM, Hurlemann R. Oxytocin modulates social distance between males and females. J Neurosci. 2012;32(46):16074-16079. PMID 23152592. pmc.ncbi.nlm.nih.gov/articles/PMC6794013/Men already in a monogamous relationship kept about 10 to 15 centimeters more distance from an attractive woman. Single men did not.
6. 6. Holt-Lunstad J, Birmingham WA, Light KC. Influence of a “warm touch” support enhancement intervention among married couples on ambulatory blood pressure, oxytocin, alpha amylase, and cortisol. Psychosom Med. 2008;70(9):976-985. PMID 18842740. pubmed.ncbi.nlm.nih.gov/18842740/34 married couples. The intervention was touch. Oxytocin was measured, not given as a drug.
7. 7. Par Pharmaceutical. Pitocin (oxytocin injection, USP) prescribing information. FDA label, revised 2021. www.accessdata.fda.gov/drugsatfda_docs/label/2021/018261Orig1s041lbl.pdfThe FDA-approved injection is for medically indicated labor and for uterine contraction after birth. Bonding and counseling are not on the label.
8. 8. AbbVie. Vyleesi (bremelanotide) prescribing information. FDA label, 2025. www.accessdata.fda.gov/drugsatfda_docs/label/2025/022526s013lbl.pdfNausea is the most common side effect named on this label. A compounded PT-141 gummy is not Vyleesi.